APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C-X-C Chemokine Receptor Type 2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global C-X-C Chemokine Receptor Type 2 Market Analysis and Forecast 2026-2032

Report ID 173973480219 December 2025196 pages

Choose your research edition.

Industry ResearchC-X-C Chemokine Receptor Type 2 Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal C-X-C Chemokine Receptor Type 2 Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal C-X-C Chemokine Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-X-C Chemokine Receptor Type 2 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal C-X-C Chemokine Receptor Type 2 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global C-X-C Chemokine Receptor Type 2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for C-X-C Chemokine Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for C-X-C Chemokine Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for C-X-C Chemokine Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for C-X-C Chemokine Receptor Type 2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of C-X-C Chemokine Receptor Type 2 include ChemoCentryx Inc, Dompe Farmaceutici SpA, Syntrix Biosystems Inc, AstraZeneca Plc, GlaxoSmithKline Plc and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for C-X-C Chemokine Receptor Type 2, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of C-X-C Chemokine Receptor Type 2, also provides the revenue of main regions and countries. Of the upcoming market potential for C-X-C Chemokine Receptor Type 2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the C-X-C Chemokine Receptor Type 2 revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global C-X-C Chemokine Receptor Type 2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for C-X-C Chemokine Receptor Type 2 revenue, projected growth trends, production technology, application and end-user industry.

C-X-C Chemokine Receptor Type 2 Segment by Company

ChemoCentryx Inc

Dompe Farmaceutici SpA

Syntrix Biosystems Inc

AstraZeneca Plc

GlaxoSmithKline Plc

Novartis AG

C-X-C Chemokine Receptor Type 2 Segment by Type

SX-517

PAC-G31P

DF-2755A

AZD-5069

Others

C-X-C Chemokine Receptor Type 2 Segment by Application

Prostate Cancer

Cornary Artery Disease

Liver Transplant Rejection

Pulmonary Inflammation

Others

C-X-C Chemokine Receptor Type 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-X-C Chemokine Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-X-C Chemokine Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-X-C Chemokine Receptor Type 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of C-X-C Chemokine Receptor Type 2 in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of C-X-C Chemokine Receptor Type 2 company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C-X-C Chemokine Receptor Type 2 revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. SX-517 Major Player Table 3. PAC-G31P Major Player Table 4. DF-2755A Major Player Table 5. AZD-5069 Major Player Table 6. Others Major Player Table 7. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Prostate Cancer Major Player Table 9. Cornary Artery Disease Major Player Table 10. Liver Transplant Rejection Major Player Table 11. Pulmonary Inflammation Major Player Table 12. Others Major Player Table 13. C-X-C Chemokine Receptor Type 2 Industry Trends Table 14. C-X-C Chemokine Receptor Type 2 Industry Drivers Table 15. C-X-C Chemokine Receptor Type 2 Industry Opportunities and Challenges Table 16. C-X-C Chemokine Receptor Type 2 Industry Restraints Table 17. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2021-2026) & (US$ Million) Table 19. Global C-X-C Chemokine Receptor Type 2 Market Share by Region (2021-2026) Table 20. Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2027-2032) & (US$ Million) Table 21. Global C-X-C Chemokine Receptor Type 2 Market Share by Region (2027-2032) Table 22. Global C-X-C Chemokine Receptor Type 2 Revenue by Players (US$ Million) & (2021-2026) Table 23. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Players (2021-2026) Table 24. Global C-X-C Chemokine Receptor Type 2 Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global C-X-C Chemokine Receptor Type 2 Key Players Headquarters & Area Served Table 26. Global C-X-C Chemokine Receptor Type 2 Players, Product Type & Application Table 27. Global C-X-C Chemokine Receptor Type 2 Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global C-X-C Chemokine Receptor Type 2 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global C-X-C Chemokine Receptor Type 2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 32. Global C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 33. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2021-2026) Table 34. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2027-2032) Table 35. Global C-X-C Chemokine Receptor Type 2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 37. Global C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 38. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2021-2026) Table 39. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2027-2032) Table 40. ChemoCentryx Inc Company Information Table 41. ChemoCentryx Inc Business Overview Table 42. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 44. ChemoCentryx Inc Recent Development Table 45. Dompe Farmaceutici SpA Company Information Table 46. Dompe Farmaceutici SpA Business Overview Table 47. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product Portfolio Table 49. Dompe Farmaceutici SpA Recent Development Table 50. Syntrix Biosystems Inc Company Information Table 51. Syntrix Biosystems Inc Business Overview Table 52. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 54. Syntrix Biosystems Inc Recent Development Table 55. AstraZeneca Plc Company Information Table 56. AstraZeneca Plc Business Overview Table 57. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 59. AstraZeneca Plc Recent Development Table 60. GlaxoSmithKline Plc Company Information Table 61. GlaxoSmithKline Plc Business Overview Table 62. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product Portfolio Table 64. GlaxoSmithKline Plc Recent Development Table 65. Novartis AG Company Information Table 66. Novartis AG Business Overview Table 67. Novartis AG C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Novartis AG C-X-C Chemokine Receptor Type 2 Product Portfolio Table 69. Novartis AG Recent Development Table 70. North America C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 71. North America C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 72. North America C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 73. North America C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 74. North America C-X-C Chemokine Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America C-X-C Chemokine Receptor Type 2 Revenue by Country (2021-2026) & (US$ Million) Table 76. North America C-X-C Chemokine Receptor Type 2 Revenue by Country (US$ Million) & (2027-2032) Table 77. Europe C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 78. Europe C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 79. Europe C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 80. Europe C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 81. Europe C-X-C Chemokine Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe C-X-C Chemokine Receptor Type 2 Revenue by Country (2021-2026) & (US$ Million) Table 83. Europe C-X-C Chemokine Receptor Type 2 Revenue by Country (US$ Million) & (2027-2032) Table 84. China C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 85. China C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 86. China C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 87. China C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 89. Asia C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 90. Asia C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 91. Asia C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 92. Asia C-X-C Chemokine Receptor Type 2 Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia C-X-C Chemokine Receptor Type 2 Revenue by Region (US$ Million) & (2021-2026) Table 94. Asia C-X-C Chemokine Receptor Type 2 Revenue by Region (US$ Million) & (2027-2032) Table 95. SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026) & (US$ Million) Table 96. SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032) & (US$ Million) Table 97. SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026) & (US$ Million) Table 98. SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032) & (US$ Million) Table 99. SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Country (2021-2026) & (US$ Million) Table 101. SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Country (US$ Million) & (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. C-X-C Chemokine Receptor Type 2 Image Figure 2. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C-X-C Chemokine Receptor Type 2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. SX-517 Image Figure 5. PAC-G31P Image Figure 6. DF-2755A Image Figure 7. AZD-5069 Image Figure 8. Others Image Figure 9. Global C-X-C Chemokine Receptor Type 2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global C-X-C Chemokine Receptor Type 2 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Prostate Cancer Image Figure 12. Cornary Artery Disease Image Figure 13. Liver Transplant Rejection Image Figure 14. Pulmonary Inflammation Image Figure 15. Others Image Figure 16. Global C-X-C Chemokine Receptor Type 2 Market Size (US$ Million) & (2021-2032) Figure 17. Global C-X-C Chemokine Receptor Type 2 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global C-X-C Chemokine Receptor Type 2 Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global C-X-C Chemokine Receptor Type 2 Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global C-X-C Chemokine Receptor Type 2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2021-2032) Figure 24. Global C-X-C Chemokine Receptor Type 2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2021-2032) Figure 27. North America C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032) Figure 29. North America C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032) Figure 30. North America C-X-C Chemokine Receptor Type 2 Revenue Share by Country (2021-2032) Figure 31. United States C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032) Figure 36. Europe C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032) Figure 37. Europe C-X-C Chemokine Receptor Type 2 Revenue Share by Country (2021-2032) Figure 38. Germany C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032) Figure 48. China C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032) Figure 49. Asia C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032) Figure 51. Asia C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032) Figure 52. Asia C-X-C Chemokine Receptor Type 2 Revenue Share by Region (2021-2032) Figure 53. Japan C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032) Figure 61. SAMEA C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032) Figure 62. SAMEA C-X-C Chemokine Receptor Type 2 Revenue Share by Country (2021-2032) Figure 63. Brazil C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt C-X-C Chemokine Receptor Type 2 Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • SX-517
  • PAC-G31P
  • DF-2755A
  • AZD-5069
  • Others
Applications
  • Prostate Cancer
  • Cornary Artery Disease
  • Liver Transplant Rejection
  • Pulmonary Inflammation
  • Others
Companies covered
  • ChemoCentryx Inc
  • Dompe Farmaceutici SpA
  • Syntrix Biosystems Inc
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 C-X-C Chemokine Receptor Type 2 Market by Type
  3. 1.2.1 Global C-X-C Chemokine Receptor Type 2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 SX-517
  5. 1.2.3 PAC-G31P
  6. 1.2.4 DF-2755A
  7. 1.2.5 AZD-5069
  8. 1.2.6 Others
  9. 1.3 C-X-C Chemokine Receptor Type 2 Market by Application
  10. 1.3.1 Global C-X-C Chemokine Receptor Type 2 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Prostate Cancer
  12. 1.3.3 Cornary Artery Disease
  13. 1.3.4 Liver Transplant Rejection
  14. 1.3.5 Pulmonary Inflammation
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 C-X-C Chemokine Receptor Type 2 Market Dynamics
  1. 2.1 C-X-C Chemokine Receptor Type 2 Industry Trends
  2. 2.2 C-X-C Chemokine Receptor Type 2 Industry Drivers
  3. 2.3 C-X-C Chemokine Receptor Type 2 Industry Opportunities and Challenges
  4. 2.4 C-X-C Chemokine Receptor Type 2 Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global C-X-C Chemokine Receptor Type 2 Market Perspective (2021-2032)
  2. 3.2 Global C-X-C Chemokine Receptor Type 2 Growth Trends by Region
  3. 3.2.1 Global C-X-C Chemokine Receptor Type 2 Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2021-2026)
  5. 3.2.3 Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global C-X-C Chemokine Receptor Type 2 Revenue by Players
  2. 4.1.1 Global C-X-C Chemokine Receptor Type 2 Revenue by Players (2021-2026)
  3. 4.1.2 Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global C-X-C Chemokine Receptor Type 2 Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global C-X-C Chemokine Receptor Type 2 Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global C-X-C Chemokine Receptor Type 2 Key Players Headquarters & Area Served
  7. 4.4 Global C-X-C Chemokine Receptor Type 2 Players, Product Type & Application
  8. 4.5 Global C-X-C Chemokine Receptor Type 2 Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global C-X-C Chemokine Receptor Type 2 Market CR5 and HHI
  11. 4.6.3 2025 C-X-C Chemokine Receptor Type 2 Tier 1, Tier 2, and Tier 3
5 C-X-C Chemokine Receptor Type 2 Market Size by Type
  1. 5.1 Global C-X-C Chemokine Receptor Type 2 Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2032)
  3. 5.3 Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Type (2021-2032)
6 C-X-C Chemokine Receptor Type 2 Market Size by Application
  1. 6.1 Global C-X-C Chemokine Receptor Type 2 Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2032)
  3. 6.3 Global C-X-C Chemokine Receptor Type 2 Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ChemoCentryx Inc
  2. 7.1.1 ChemoCentryx Inc Company Information
  3. 7.1.2 ChemoCentryx Inc Business Overview
  4. 7.1.3 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product Portfolio
  6. 7.1.5 ChemoCentryx Inc Recent Developments
  7. 7.2 Dompe Farmaceutici SpA
  8. 7.2.1 Dompe Farmaceutici SpA Company Information
  9. 7.2.2 Dompe Farmaceutici SpA Business Overview
  10. 7.2.3 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product Portfolio
  12. 7.2.5 Dompe Farmaceutici SpA Recent Developments
  13. 7.3 Syntrix Biosystems Inc
  14. 7.3.1 Syntrix Biosystems Inc Company Information
  15. 7.3.2 Syntrix Biosystems Inc Business Overview
  16. 7.3.3 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product Portfolio
  18. 7.3.5 Syntrix Biosystems Inc Recent Developments
  19. 7.4 AstraZeneca Plc
  20. 7.4.1 AstraZeneca Plc Company Information
  21. 7.4.2 AstraZeneca Plc Business Overview
  22. 7.4.3 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product Portfolio
  24. 7.4.5 AstraZeneca Plc Recent Developments
  25. 7.5 GlaxoSmithKline Plc
  26. 7.5.1 GlaxoSmithKline Plc Company Information
  27. 7.5.2 GlaxoSmithKline Plc Business Overview
  28. 7.5.3 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product Portfolio
  30. 7.5.5 GlaxoSmithKline Plc Recent Developments
  31. 7.6 Novartis AG
  32. 7.6.1 Novartis AG Company Information
  33. 7.6.2 Novartis AG Business Overview
  34. 7.6.3 Novartis AG C-X-C Chemokine Receptor Type 2 Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Novartis AG C-X-C Chemokine Receptor Type 2 Product Portfolio
  36. 7.6.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America C-X-C Chemokine Receptor Type 2 Revenue (2021-2032)
  2. 8.2 North America C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2032)
  3. 8.2.1 North America C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026)
  4. 8.2.2 North America C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032)
  5. 8.3 North America C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 8.4 North America C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2032)
  7. 8.4.1 North America C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026)
  8. 8.4.2 North America C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032)
  9. 8.5 North America C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 8.6 North America C-X-C Chemokine Receptor Type 2 Revenue by Country
  11. 8.6.1 North America C-X-C Chemokine Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America C-X-C Chemokine Receptor Type 2 Revenue by Country (2021-2026)
  13. 8.6.3 North America C-X-C Chemokine Receptor Type 2 Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe C-X-C Chemokine Receptor Type 2 Revenue (2021-2032)
  2. 9.2 Europe C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2032)
  3. 9.2.1 Europe C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026)
  4. 9.2.2 Europe C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032)
  5. 9.3 Europe C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 9.4 Europe C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2032)
  7. 9.4.1 Europe C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026)
  8. 9.4.2 Europe C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032)
  9. 9.5 Europe C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 9.6 Europe C-X-C Chemokine Receptor Type 2 Revenue by Country
  11. 9.6.1 Europe C-X-C Chemokine Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe C-X-C Chemokine Receptor Type 2 Revenue by Country (2021-2026)
  13. 9.6.3 Europe C-X-C Chemokine Receptor Type 2 Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China C-X-C Chemokine Receptor Type 2 Revenue (2021-2032)
  2. 10.2 China C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2032)
  3. 10.2.1 China C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026)
  4. 10.2.2 China C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032)
  5. 10.3 China C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 10.4 China C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2032)
  7. 10.4.1 China C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026)
  8. 10.4.2 China C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032)
  9. 10.5 China C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia C-X-C Chemokine Receptor Type 2 Revenue (2021-2032)
  2. 11.2 Asia C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2032)
  3. 11.2.1 Asia C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026)
  4. 11.2.2 Asia C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032)
  5. 11.3 Asia C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 11.4 Asia C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2032)
  7. 11.4.1 Asia C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026)
  8. 11.4.2 Asia C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032)
  9. 11.5 Asia C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 11.6 Asia C-X-C Chemokine Receptor Type 2 Revenue by Country
  11. 11.6.1 Asia C-X-C Chemokine Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia C-X-C Chemokine Receptor Type 2 Revenue by Country (2021-2026)
  13. 11.6.3 Asia C-X-C Chemokine Receptor Type 2 Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA C-X-C Chemokine Receptor Type 2 Revenue (2021-2032)
  2. 12.2 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Type (2027-2032)
  5. 12.3 SAMEA C-X-C Chemokine Receptor Type 2 Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Application (2027-2032)
  9. 12.5 SAMEA C-X-C Chemokine Receptor Type 2 Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Country
  11. 12.6.1 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA C-X-C Chemokine Receptor Type 2 Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst